Journal of Clinical and Translational Hepatology · 2023 · 15 citations · 18 references
MedicineOncologySurgeryHepatologyOncologic SurgerySurgical OncologyCancer StagingHepatobiliary CancerHepatocellular CarcinomaLiver CancerLiver DiseaseTumor StagingHepatic MalignancyHepatic TumorsHepatocellular Carcinoma TreatmentPrognostic CriteriaPrognostic ModelsPrognostic Prediction
Background and Aims: To validate prognostic performance of the China liver cancer (CNLC) staging system as well as to compare these parameters with those of the Barcelona Clinic Liver Cancer (BCLC) staging system for Chinese hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE). Methods: This multicenter retrospective study included 1,124 patients with HCC between January 2012 and December 2020 from six Chinese hospitals. Based on overall survival (OS), the prognostic performance outcomes for the CNLC and BCLC staging systems were compared by model discrimination [C statistic and Akaike information criterion (AIC)], monotonicity of the gradient (linear trend chi-square test), homogeneity (likelihood ratio chi-square test), and calibration (calibration plots). A prospective cohort of 44 patients receiving TACE-based therapy included between January 2021 and December 2022 was used to prospectively validate the outcomes. Results: <0.001). Both staging systems had good model calibration. Similar results were observed in the prospective cohort. Conclusions: Combining model discrimination, gradient monotonicity, homogeneity, and calibration, the CNLC performed better than the BCLC for Chinese HCC patients receiving TACE.
18
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Assessing the Performance of Prediction Models
Ewout W. Steyerberg, Andrew J. Vickers, Nancy R. Cook et al. · Epidemiology · 2009 · 4.9K citations · Full text